Details for 2021174249

Up to date per 03.04.2026

Actions

Title / Product Name

AUGMENTIERTE ALPHA-GLUCOSIDASE ZUR BEHANDLUNG VON MORBUS POMPE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021174249

EP Publication Number

3957320

E-Number

1601796

Language

PCT Number

Publication Date

23.02.2022 A

23.08.2023 B1

Registration Date

23.08.2023

AT Publication Date

15.09.2023

Application Date

29.12.2016

Registration Number

Priorities

30.12.2015

201562272890 P

26.02.2016

201662300479 P

30.03.2016

201662315412 P

30.09.2016

201662402454 P

01.12.2016

201662428867 P

08.12.2016

201662431791 P

IPC

A61K 38/47 20060101AFI20220114BHEP

Maximum Duration of Protection

29.12.2036

Owner

Amicus Therapeutics, Inc.3675 Market Street Philadelphia, PA 19104US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

DO, Hung V. Philadelphia, 19104US

KHANNA, Richie Philadelphia, 19104US

GOTSCHALL, Russell Philadelphia, 19104US

Information about Fees